Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of 07741_FLUKA on PharmaCompass.com

    Client Email Product

    07741_FLUKA

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    43
    US DMFs Filed

    US DMFs Filed

    18
    CEP/COS Certifications

    CEP/COS Certifications

    11
    JDMFs Filed

    JDMFs Filed

    2
    Other Certificates

    Other Certificates

    4
    Other Suppliers

    Other Suppliers

    31
    API REF. PRICE (USD / KG)
    256,282

    API Market Place

    16
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    53
    Europe

    Europe

    5
    Canada

    Canada

    12
    Australia

    Australia

    12
    South Africa

    South Africa

    184
    Uploaded Dossiers

    Uploaded Dossiers

    14
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    3,211.00

    Annual Reports

    2,020.00

    FDF Market Place

    11
    EXCIPIENTS
    173
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    12

    USFDA Exclusivities

    3
    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    70
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    4
    SERVICES
    1
    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    8410131*PED
    2026-05-01
    22334
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    9006224
    2028-07-01
    U-1681
    22334
    TREATMENT OF PATIENTS WITH PROGESSIVE NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET) THAT ARE UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    8410131
    2025-11-01
    U-1368
    22334
    TREATMENT OF SOLID EXCRETORY SYSTEM TUMORS; ADVANCED RENAL CELL CARCINOMA (RCC), AFTER FAILURE OF TREATMENT WITH SUNITINIB OR SORAFENIB
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    8410131*PED
    2026-05-01
    22334
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    8410131
    2025-11-01
    U-1368
    22334
    TREATMENT OF SOLID EXCRETORY SYSTEM TUMORS; ADVANCED RENAL CELL CARCINOMA (RCC), AFTER FAILURE OF TREATMENT WITH SUNITINIB OR SORAFENIB
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    9006224
    2028-07-01
    U-1681
    22334
    TREATMENT OF PATIENTS WITH PROGESSIVE NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET) THAT ARE UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    8410131
    2025-11-01
    U-1368
    22334
    TREATMENT OF SOLID EXCRETORY SYSTEM TUMORS; ADVANCED RENAL CELL CARCINOMA (RCC), AFTER FAILURE OF TREATMENT WITH SUNITINIB OR SORAFENIB
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    8410131*PED
    2026-05-01
    22334
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    9006224
    2028-07-01
    U-1681
    22334
    TREATMENT OF PATIENTS WITH PROGESSIVE NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET) THAT ARE UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    8410131
    2025-11-01
    U-1368
    22334
    TREATMENT OF SOLID EXCRETORY SYSTEM TUMORS; ADVANCED RENAL CELL CARCINOMA (RCC), AFTER FAILURE OF TREATMENT WITH SUNITINIB OR SORAFENIB
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    8410131*PED
    2026-05-01
    22334
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EVEROLIMUS

    PDF Supplier PDF
    URL Supplier Web Content
    9006224
    2028-07-01
    U-1681
    22334
    TREATMENT OF PATIENTS WITH PROGESSIVE NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET) THAT ARE UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search